OBJECTIVE: NADPH oxidase 4 (NOX4) is a reactive oxygen species (ROS) producing NADPH oxidase that regulates redox homeostasis in diverse insulin-sensitive cell types. In particular, NOX4-derived ROS is a key modulator of adipocyte differentiation and mediates insulin receptor signaling in mature adipocytes in vitro. Our study was aimed at investigating the role of NOX4 in adipose tissue differentiation, whole body metabolic homeostasis and insulin sensitivity in vivo. DESIGN: Mice with genetic ablation of NOX4 (NOX4-deficient mice) were subjected to chow or high-fat-containing diet for 12 weeks. Body weight gain, adiposity, insulin sensitivity, and adipose tissue and liver gene and protein expression were analyzed and compared with similarly treated wild-type mice. RESULTS: Here, we report that NOX4-deficient mice display latent adipose tissue accumulation and are susceptible to diet-induced obesity and early onset insulin resistance. Obesity results from accelerated adipocyte differentiation and hypertrophy, and an increase in whole body energy efficiency. Insulin resistance is associated with increased adipose tissue hypoxia, inflammation and adipocyte apoptosis. In the liver, more severe diet-induced steatosis was observed due to the lack of proper upregulation of mitochondrial fatty acid b-oxidation. CONCLUSION: These findings identify NOX4 as a regulator of metabolic homeostasis. Moreover, they indicate an anti-adipogenic role for NOX4 in vivo and reveal its function as a protector against the development of diet-induced obesity, insulin resistance and hepatosteatosis.
INTRODUCTION
NADPH oxidases are pro-oxidant enzymes whose main cellular function is the production of reactive oxygen species (ROS). The best renowned member of this family is the phagocyte NADPH oxidase (gp91 phox /NOX2) mediating host defense action. 1 NADPH oxidase 4 (NOX4), another recently cloned member of the NADPH oxidase family, was originally termed 'Renox' for its predominant expression in kidney. 2, 3 NOX4 produces ROS in a constitutive manner and its regulation is achieved at the transcriptional and translational levels. 4, 5 Physiological ROS production has a key role in the intracellular insulin signal transmission and exerts a protective effect against the onset of diet-induced insulin resistance. 6, 7 NOX4 has been shown to convey a variety of cellular signaling events in different insulinsensitive tissues, for example, hepatocytes, vascular smooth muscle cells, endothelial cells and fibroblasts reviewed in. 1 In particular, NOX4 has been shown to mediate insulin-induced glucose uptake in adipocytes. 6 Insulin is also a key modulator of adipocyte differentiation both in vitro and in vivo, and NOX4 is one of the genes whose expression is regulated during the course of this process. 8 --11 Adipocyte differentiation and hypertrophy is closely linked to the onset of insulin resistance. 12 Elevated NOX4 levels have been observed in the adipose tissue in rodent models of obesity and in humans with extreme insulin resistance. 13, 14 Despite the close link between insulin signaling, ROS production and NOX4 expression in adipocytes, the role of NOX4 in the regulation of metabolic homeostasis and the development of dietinduced obesity and insulin resistance in vivo has not yet been explored. Thus, our study was aimed at investigating the metabolic phenotype of mice with genetic ablation of NOX4 (NOX4-deficient mice) and studying their response to high-fat diet (HFD) challenge. Our data demonstrate that in the absence of NOX4, mice develop latent adipose tissue hypertrophy with the molecular signature of hypoxia and inflammation. Upon HFD feeding, NOX4-deficient mice were more sensitive to the development of diet-induced obesity, insulin resistance and liver steatosis. Taken together, these data suggest that NOX4-mediated constitutive ROS production has a key role in adipose tissue function, and decreased NOX4 activity sensitizes towards the development of metabolic disorders upon nutritional challenge.
MATERIALS AND METHODS
Mice, diets and treatments NOX4-deficient mice were generated as described. 15 Genotyping was carried out by using the primers NOX4: forward 5 0 -TCATGACAGTTGGGGAC AAA3-0 ; NOX4: reverse 5 0 -TTGAAAATTCAACACAAGTCTCC3-0 for wild type (WT) and the reverse primer NOX4 Neo R 5 0 -AACGTCGTGACTGGGAAAAC-3 0 for the mutant allele. WT and NOX4-deficient mice were housed in conventional animal facility in individual cages under controlled temperature (23 1C) and illumination (12-h light/12-h dark cycle). Ten-to elevenweek-old male mice were given either standard chow or HFD (60% of energy as fat, cat: 2127, Provimi Kliba AG, Kaiseraugst, Switzerland) for a period of 12 weeks. All mice were allowed ad libitum access to water. Mice were killed in the non-fasted state. The experimental protocol had been accepted by the Ethical Committee of the University of Geneva and the Veterinary Office of the Canton of Geneva.
Measurement of whole body fat and lean mass
Whole body fat and lean mass was measured by dual-energy X-ray absorptiometry (PIXImus2, GE Lunar, Madison, WI, USA) as described previously. 16 Intraperitoneal glucose, insulin and pyruvate tolerance tests (ipGTT, ipITT and ipPTT)
Mice were fasted overnight and were administered intraperitoneally with 2 mg kg À1 glucose (ipGTT), 1 U kg À1 insulin (ipITT) or 2 g kg À1 sodium pyruvate (ipPTT). Glucose levels were monitored during a period of 2 h using a glucometer (Accu-check, Roche Diagnostics GmbH, Mannheim, Germany).
Metabolic cage measurements
Food and water intake, energy expenditure, respiratory quotient (RQ) and locomotor activity of mice were analyzed in a custom-made 12-cage calorimetric system (LabMaster Multipurpose Screening System; TSE Systems, Bad Homburg, Germany). The instrument consists of a combination of highly sensitive feeding and drinking sensors for automated online measurement. The calorimetric system is an open-circuit system that determines O 2 consumption, CO 2 production and RQ (RQ ¼ VCO 2 /VO 2 , where V is volume). A photobeam-based activity monitoring system detects and records every ambulatory movement, including rearing and climbing movements in every cage. Detection of animal location is performed with infrared sensor pairs arranged in strips for horizontal and vertical (rearing) activity. The sensors for detection of movement operate efficiently in both light and dark phases, allowing continuous recording. All of the parameters can be measured continuously and simultaneously in up to 12 animals. Data were collected for 48 h after a 5-day adaptation period.
Determination of body fat composition by micro-CT
In vivo micro-CT images of anesthetized mice (Nembutal, 50 mg kg À1 ip) were acquired on a Skyscan-1076 micro-CT (Skyscan, Aartselaar, Belgium) using an X-ray charge-coupled device camera with a cooled 1024 Â 1024-pixel 12-bit sensor (http://www.medecine.unige.ch/lafaculte/services/ phenotypage). The camera was rotated through 1851, and images were made every 1.41, achieving an in vivo resolution of 35 mm. Reconstruction of acquired data was made through a cone-beam reconstruction method to account for the conical geometry of the X-ray source. After reconstruction, fat deposition was manually segmented with Osirix and the volume of the abdominal fat was calculated from the subcutaneous, intra-peritoneal, retroperitoneal and epididymal regions as described. 17 
Serum measurements
Blood was drawn from tail vein in non-fasted state or after overnight food deprivation. In both conditions mice had ad libitum access to water. Insulin and leptin levels were determined by ELISA analysis (Ulrasensitive Mouse Insulin ELISA kit, Mercodia, Uppsala, Sweden and Mouse/Rat Leptin Enzyme Immunoassay Kit, Spi-bio, Montigny le Bretonneux, France).
Ketone body levels were determined by Autokit Total Ketone Bodies (Wako Chemicals, Neuss, Germany).
Histology and morphometric measurements
Tissue samples were fixed in 4% paraformaldehyde, embedded in paraffin, and serial sections were subjected to standard hematoxylin/eosin, acid fuchsin orange G and periodic acid Schiff (PAS) stainings as specified. Sections were evaluated in a blind manner by an independent pathologist. White adipose tissue morphometric measurements were conducted on hematoxylin/eosin-stained duplicate sections derived from three different levels of tissue (six images per mouse). Images were obtained by Axiocam Imaging Sytem (Carl Zeiss AG, Feldbach, Switzerland). Cell diameter was calculated from computer-assisted image transformation using MetaMorph Image Analysis software (Molecular Devices, Union City, CA, USA), as described in Supplementary Figure S6 .
Liver lipid and glycogen content Liver lipids were extracted by modified Folch method. 18 In brief, 50 --100 mg tissues were homogenized by Potter-Elvehjem Tissue Grinder with Teflon Pestle in the solution of chloroform:methanol (2:1) and the lipids were extracted overnight. After the addition of 1/5 volume of 0.9% NaCl solution the mixture was centrifuged at 1000 r.p.m. The lower organic (lipid-containing) phase was dried and lipids were then resuspended in 250 mL of absolute ethanol and stored at À20 1C until analyzed. Triglyceride levels were determined by a commercial kit (Roche Diagnostics, Rotkrauz, Switzerland).
Liver glycogen was extracted according as described. 19 In brief, 50 --150 mg frozen tissue samples were digested in a suitable volume of 30% KOH for 10 min at 100 1C. Digestion was completed by the addition of 1/5 volume of 20% NaSO 4 . Macromolecules were precipitated by the addition of two volumes of absolute ethanol and overnight incubation at À20 1C. Precipitates were washed with 70% ethanol and dried, and then glycogen was hydrolyzed by digestion in 500 ml of 4N H 2 SO 4 for 10 min at 100 1C. Samples were neutralized by the addition of an equivalent volume of 4N NaOH and then deproteinized by equal volumes of Ba(OH)2 and ZnSO 4 . Glucose was quantified using the GAGO-20 kit (Sigma-Aldrich Chemie GmbH, Buchs, Switzerland).
Islet insulin content measurements
For determination of insulin content, pancreas were extracted for 24 h at 4 1C in acid-ethanol and sonicated. Aliquots of the extracts were assayed by RIA using 125I-insulin as a tracer, a specific antibody to insulin (Linco Research, St Charles, MO, USA) and rat insulin as standard.
RNA isolation and quantitative real-time PCR
Total RNA was prepared in TRIZOL Reagent (Invitrogen, Basel, Switzerland) and was purified by using the RNeasy Mini Kit (Qiagen, Hombrechtikon, Switzerland). cDNA was synthesized from 2 mg of DNA-free RNA by Superscript II Reverse Transcriptase (Invitrogen). The primers used for quantitative real-time PCR are listed in the Supplementary Table S1. Realtime PCR reactions were carried out using Sybergreen in an ABI 7500 instrument (Applied Biosystems, Rotkreuz, Switzerland). The results were quantified by the DCt method using cyclophillin A as the standard internal non-variable gene to compensate for differences in RNA input and efficiency of cDNA synthesis. Results were expressed as arbitrary units compared to the average expression levels in WT mice.
Western blot analysis
Tissues were snap-frozen in liquid nitrogen immediately upon removal and were stored at À80 1C till processing. Samples were homogenized in RIPA buffer (150 mM NaCl, 1% NP40, 0.1% SDS, 0.5% deoxycholic sodium salt, 50 mM Tris HCl, pH 7.4, 2 mM EDTA, 2 mM Na 3 VO 4 , 10 mM NaF, one tablet of Complete Inhibitor Cocktail (Roche Diagnostics) in 30 ml). Protein concentration was measured by bicinchoninic acid method (Pierce, Rockford, IL, USA). Lysates were dissolved in Laemmli buffer (10 mM sodium phosphate, pH 7.0, 0.1% glycerol, 2% SDS, 100 mM DTT and a trace of BPB) and were resolved on a 5 --20% gradient polyacrylamide gel. Gels were transferred onto nitrocellulose membranes (GE Healthcare, Otelfingen, Switzerland) followed by incubation with the respective primary antibodies. Antibodies are listed in Supplementary Table S2 . Blots were then washed and subsequently incubated with the applicable secondary horseradish peroxidase-conjugated antibody (Sigma-Aldrich, Buch, Switzerland). Signals were revealed by enhanced chemiluminescence and were recorded in ChemiDoc XRS system. Quantification of the detected bands was performed by using the Quantity One program (BioRad Laboratories, Reinach, Switzerland). Protein expression was related to the amount of actin as a non-variable reference protein and was expressed as arbitrary units compared to the average expression in WT mice.
Statistical analysis
Data are expressed as mean±s.e.m. Results were analyzed by using ANOVA or Student's t test, or in case of non-parametric data distribution by Mann --Whitney test using the Sigma Stat software (version 2.0---SPSS, Chicago, IL, USA). P-values less than 0.05 were considered significant.
RESULTS
Diet-induced obesity and insulin resistance in NOX4-deficient mice Generation of NOX4-deficient mice were carried out by classical gene recombination deleting exon 4 coding for the catalytic center of NOX4 as described 15 (Supplementary Figure S1 ). To assess the effect of NOX4 deletion on adipose tissue function and metabolic homeostasis, we compared body weight gain, glucose tolerance and insulin sensitivity in several cohorts of WT and NOX4-deficient mice kept under regular chow diet-fed between 10 --22 weeks of age. NOX4-deficient mice had slightly but significantly increased body weight compared with WT mice of the same age ( Figure 1a ). This increase in body weight was due to more pronounced fat accumulation as established by dualenergy X-ray absorptiometry and micro-CT scanning, particularly of abdominal fat (Figures 1b and c) . Despite their adiposity, NOX4-deficient mice did not show any difference in glucose tolerance or in insulin sensitivity evaluated by ipGTT and ipITT, respectively (data not shown).
In order to exacerbate obesity development, we challenged WT and NOX4-deficient mice with a HFD for a period of 12 weeks. Indeed, upon HFD challenge, NOX4-deficient mice displayed significantly elevated body weight gain as early as 2 weeks after the initiation of the diet (Figure 2a ). At sacrifice, a more prominent accumulation of epidydimal (WATe) and inguinal (WATi) adipose tissue was confirmed ( Figure 2b ). Food intake, heat production and physical activity were analyzed by housing mice in metabolic cages after 12 weeks of chow or HFD feeding. HFD-fed NOX4-deficient mice presented slightly higher night-period food intake compared with HFD-fed WT mice (Figure 2c ). However, the most prominent HFD-related metabolic change was observed in energy efficiency (weight gain/calorie consumed) that was increased twofold in NOX4-deficient mice (Figure 2d ). The ratio between the utilization of carbohydrates or lipids (RQ), ambulatory movement and energy expenditure was similar in HFD-fed WT and NOX4-deficient mice ( Supplementary Figures S2a and b) . In line with their increased adipose tissue mass, HFD-fed NOX4-deficient mice displayed significantly elevated serum leptin levels after 12 weeks of HFD feeding (Figure 2e) .
Obesity is the most common risk factor associated with hyperglycemia and insulin resistance. Indeed, parallel to their increased HFD-induced weight gain NOX4-deficient mice displayed elevated fasted serum glucose levels compared with WT mice after 4 weeks of HFD administration. This increase was reversed after 12 weeks, at which point serum glucose levels were indistinguishable between WT and NOX4-deficient mice, most likely due to a higher degree of HFD-induced raise in insulin levels (Figures 2f and g ). HOMA values indicated more severe insulin resistance in NOX4-deficient mice after both 4 and 12 weeks of HFD (Figure 2h ). Exaggerated HFD-induced insulin resistance in NOX4-deficient mice was also confirmed by ipITT (Figure 2i ). ipGTT showed no significant differences between HFD-fed WT and NOX4-deficient mice (Supplementary Figure S2b) . As an adaptative mechanism, pancreas insulin content was slightly elevated in HFD-fed NOX4-deficient mice without any obvious morphological changes in islet morphology or size (Supplementary Figures S2c --e) .
HFD-induced white adipose tissue hypertrophy, hypoxia, inflammation and apoptosis in NOX4-deficient mice Insulin resistance is closely linked to adipocyte differentiation and hypertrophy. 20, 21 Epididymal white adipose tissue of both chow and HFD-fed NOX4-deficient mice presented larger adipocytes analyzed either as mean cell size or cell size distribution ( Figures  3a and b) . Along with adipose tissue hyperthrophy, molecular signs of enhanced adipocyte differentiation and adipose tissue remodeling/hypertrophy were observed. Namely, in chow diet-fed NOX4-deficient mice a decrease in the expression of preadipocyte factor 1 (Pref-1) and an increase in the expressions of SPARC (secreted protein acidic cystein-rich) and vascular endothelial growth factor (VEGF) were noted (Figures 3c --e) . HFD regime induced exaggerated elevation in the expressions of SPARC and metalloproteinase 2 (MMP-2), and higher mRNA expression of the adipocyte differentiation marker leptin in NOX4-deficient mice (Figures 3f and g ). Hypertrophic adipose tissue is characterized by insufficient blood supply relative to the increased demand from hypertrophic adipocytes triggering the onset of hypoxia, followed by macrophage infiltration and an elevation in inflammatory cytokine production. 12,22 --25 In line with their hypertrophic adipose tissue, HFD-fed NOX4-deficient mice showed increased mRNA expressions of hypoxia-inducible factor 1 (HIF-1a), macrophage chemoattractant protein-1 (MCP-1), the macrophage signature protein F4/80 and the pro-inflammatory factors TNFa and PAI-1 (Figures 3h --j) . Accordingly, increased protein level of NF-kB, the master transcriptional regulator of inflammatory response, was observed (Figure 3k ). Adipose tissue inflammation triggers adipocyte apoptosis through activation of the effector protease caspase 3.
26 HFD-fed NOX4-deficient mice presented increased amount of the activated (cleaved) form of caspase 3 ( Figure 3l ). Peroxisome proliferator-activated receptor g (PPARg) is a major regulator of adipogenesis and adipose tissue insulin sensitivity. 27 PPARg protein levels were reduced in chow diet-fed NOX4-deficient mice compared with WT mice. HFD feeding led to a decrease in PPARg expression in both WT and NOX4-deficient mice that diminished the difference between genotypes (P ¼ 0.013 Student's t-test) (Figure 3m ). CCAAT-enhancer-binding protein alpha (C/EBPa) cooperates with PPARg to promote adipose tissue differentiation and to induce transcription of the insulinsensitive glucose transporter 4 (GLUT4). 28, 29 Both C/EBPa and GLUT4 expressions were downregulated in HFD-fed NOX4-deficient mice compared with WT mice (Figure 3n ).
Obesity and the development of metabolic syndrome are associated with differential regulation of several adipose tissue microRNAs. Namely, miR-134 is related to insulin sensitivity and chronic hyperglycemia, whereas miR-132 is linked to obesityinduced adipose tissue inflammation in humans. 30 HFD-fed NOX4-deficient mice showed increased miR-134 and miR-132 expression compared with WT mice on the same regime (Figure 3o ). Upregulation of miR-143 was associated with HFD-induced obesity, and miR-21 has been shown to regulate adipogenic differentiation of mesenchymal stem cells. 31, 32 NOX4-deficient mice displayed similar miR-143 and miR-21 levels to WT mice regardless of the diet (data not shown).
Increased cold tolerance in NOX4-deficient mice Brown adipose tissue increases energy expenditure and is an important organ in the regulation of metabolic homeostasis. NOX4-deficient mice developed higher amount of brown adipose tissue under HFD regime parallel to a more significant lipid accumulation in this tissue (Figures 4a and b) . Chow diet-fed NOX4-deficient mice displayed attenuated PPARg mRNA levels that were similar to the levels observed in WT mice upon HFDfeeding (Figure 4c ). Uncoupling protein-1 (UCP-1) is a brown adipose tissue-specific mitochondrial protein inducing nonshivering thermogenesis, thus increasing energy expenditure. NOX4-deficient mice had increased UCP-1 expression under both chow and HFD regime (Figure 4d ). When control, chow diet-fed mice were challenged by cold exposure at 4 1C, NOX4-deficient mice maintained their body temperature more efficiently than WT mice (Figure 4e ).
HFD-induced liver steatosis in NOX4-deficient mice
Obesity is associated with the occurrence of non-alcoholic fatty liver disease, characterized by intrahepatic triglyceride accumulation. In line with their adiposity, HFD-fed NOX4-deficient mice displayed elevated hepatic triglyceride storage in the form of small lipid droplets (Figures 5a and b) . Accordingly, liver weight was increased in HFD-fed NOX4-deficient mice compared with HFD-fed WT mice (1.51 ± 0.24gr and 1.76 ± 0.33gr, WT vs NOX4-deficient mice, respectively, P ¼ 0.041, Student's t test). Steatosis develops when the rate of fatty acid (FA) input (uptake and synthesis) is greater than the rate of FA output (secretion and oxidation). HFD-fed NOX4-deficient mice displayed comparable levels of the FA transporter CD36 (FA uptake), a decrease in the levels of the acetyl-coA carboxylase (ACC) (the rate-limiting enzyme of FA synthesis) and equal amounts of the microsomal triglyceride transfer protein (MTTP) (triglyceride export), suggesting that these processes do not have a crucial role in the onset of exacerbated hepatosteatosis (Supplementary Figures S3a --c) . By contrast, a role for decreased mitochondrial FA b-oxidation was implied by the lack of diet-induced upregulation of the expression of the rate-limiting enzyme carnitin-palmitoyl transport protein 1 (CPT-1). CPT-1 expression is regulated by the transcription factor PPARa, and impaired PPARa activity leads to increased fat storage in liver. 33, 34 PPARa levels were decreased in HFD-fed NOX4-deficient mice (Figure 5c ). No alteration was observed in the expression of acyl-coA oxidase (AOX), the rate-limiting enzyme of peroxisomal FA oxidation (Figure 5d ). Serum ketone body concentrations were elevated in NOX4-deficient mice already after 2 weeks of HFD feeding (218±9.21 and 337±13.9 mM for WT and for NOX4-deficient mice, respectively, Student's t-test Po0.001). Liver triglyceride synthesis is mediated by diglyceride acyltransferases 1 and 2 (DGAT1 and 2). 3-Hydroxy-3-methylglutaryl-coenzyme A synthase (HMG-CoA synthase) is the ratelimiting enzyme of cholesterol biosynthesis. Both DGAT 1/2 and HMG-CoA synthase expressions were downregulated in chow dietfed NOX4-deficient mice reaching similar levels than in HFD-fed WT mice (Figure 5e ).
Liver is a major site of glucose homeostasis regulation through its glycogen storage and neoglucogenic capacity. Liver glycogen content was elevated in HFD-fed NOX4-deficient mice (Figure 5f ). AKT phosphorylation tended to be elevated, though this increase did not reach statistical significance (Figure 5g ). Neoglucogenesis was decreased in HFD-fed NOX4-deficient mice, as shown by lower glucose levels in response to intraperitoneal injection of pyruvate, the major substrate of glucose synthesis (ipPTT) (Figure 5h) . Expression of the neoglucogenic enzymes glucose-6 phosphatase (G-6-Pase) and phospho-enol-carboxykinase (PEPCK) showed a slight but statistically non-significant decrease, pointing towards a regulation at the level of enzyme activity (Supplementary Figure S3d) .
NOX4 possesses constitutive NADPH oxidase activity transforming NADPH into NADP þ . 4 Glucose-6-phosphate-1-dehydrogenase (G-6-PD) is the rate-limiting enzyme of the alternative glucose utilization pathway (pentose-phosphate shunt) that is regulated in response to alterations in the cellular NADPH/NADP þ ratio. The expression of G-6-PD was significantly decreased in chow diet-fed NOX4-deficient mice reaching levels that were comparable to HFD-fed WT mice (Figure 5i ).
Liver metabolic disturbances may lead to the activation of hepatic stellate cells triggering Smad3-mediated cytoskeletal re-organization and the induction of a-smooth muscle actin (a-SMA) expression. 35 Along with increased liver lipid deposition HFD-fed NOX4-deficient mice presented higher degree of Smad3 phosphorylation (activation) but failed to upregulate a-SMA protein levels (Figure 5j ). Activated hepatic stellate cells synthesize matrix MMP-2 to degrade normal extracellular matrix. 36 MMP2 expression was increased in the livers of NOX4-deficient mice upon both chow and HFD administration (Figure 5k ). Liver steatosis is reversed by fibroblast growth factor-21 (FGF-21) in different rodent models of insulin resistance. 37 --39 Human non-alcoholic steatohepatitis, a histological entity with propensity to progress towards liver fibrosis, is characterized by lower hepatic FGF-21 expression compared to non-alcoholic fatty liver disease. 40 HFD feeding induced a significant increase in FGF-21 expression in WT mice but to a much lesser extent in NOX4-deficient mice (Figure 5l ). 
DISCUSSION
In this study, we show that NOX4 is a master regulator of metabolic homeostasis and that the absence of NOX4-mediated ROS production results in latent adipose tissue accumulation and a marked sensitivity towards diet-induced obesity and hepatosteatosis.
In the absence of nutritional challenge, NOX4-deficient mice displayed slightly but significantly increased body weight from the age of 10 weeks. Body weight increase was linked to accelerated adipose tissue differentiation and hypertrophy demonstrated by decreased expression of the preadipocyte marker Pref-1 and larger size adipocytes. HFD challenge led to massive obesity resulting from higher energy efficiency. HFD-induced obesity was accompanied by elevated circulating leptin levels and a small raise in calorie intake. This small increase (B20%) in food intake in HFDfed NOX4-deficient mice did not account for the development of obesity (200% increase in WAT) and, interestingly, was not related to a resistance to leptin's inhibitory effect on orexigenic neuropeptide expression. Indeed, the levels of neuropeptide Y and Agouti-related peptide were decreased in HFD-fed NOX4-deficient mice, suggesting a leptin-independent regulation of hypothalamic appetite centers (Supplementary Figure S4a) . These data are in line with several other studies showing the critical role of hypothalamic ROS production in appetite regulation. 41 Although in our current study, using whole body NOX4-deficient mice, HFD diet-induced obesity was not a consequence of increased calorie intake but an increase in energy efficiency, the role of NOX4 in hypothalamic function remains an intriguing question for the future investigations.
HFD-induced adipose tissue accumulation was accompanied by a molecular signature of intensive extracellular matrix remodeling (increased MMP-2 and SPARC expressions) and enhanced adipocyte differentiation (increased leptin expression), suggesting an anti-adipogenic role for NOX4 and a predisposition towards HFD-induced obesity in the absence of NOX4-derived ROS production. In vitro, decreased NOX4 function was linked to decreased p44/42MAPK activation and mitogenesis, and a concurrent enhancement of PPARg2-mediated adipogenesis. 10 In vivo, in NOX4-deficient mice, we did not observe changes in MAPK phosphorylation most likely due to differences between the in vitro and in vivo effects of NOX4 on adipocyte function (Supplementary Figure S4b) . In addition, PPARg expression was downregulated in NOX4-deficient mice, suggesting an adipogenic process independent of this classical pathway. From the energetic point, HFD-induced adipose tissue accumulation in NOX4-deficient mice was due to increased energy efficiency. In this NOX4 regulates adipogenesis in vivo Y Li et al respect, elevated expressions of the mitochondrial uncoupling proteins UCP-2 (white adipose tissue) and UCP-1 (brown adipose tissue) could be regarded as compensatory mechanisms to enhance mitochondrial function and increase energy expenditure. Taken together, these data imply that the lack of NOX4-mediated ROS production leads to increased adipocyte differentiation and enhanced triglyceride storage independent of the classical adipogenic (PPARg) and mitochondrial energy producing (UCP-1/UCP-2) pathways. The abrupt increase in adipose tissue mass in NOX4-deficient mice brought on by HFD challenge provoked the development of 'obese' adipose tissue, characterized by hypoxia, macrophage recruitment and the production of inflammatory cytokines triggering adipocyte apoptosis and the development of insulin resistance. 22, 42, 43 Indeed, NOX4-deficient mice presented elevated expressions of HIF-1a and NF-kB, the master regulators of cellular hypoxic and inflammatory responses, and their target genes TNFa, MCP-1, PAI-1 and VEGF along with enhanced activation of caspase3, the executional factor of apoptosis. The onset of whole body insulin resistance was evidenced by increased HOMA values already at very early time points (4 weeks) of HFD feeding. Enhanced NOX4 expression and NOX4-derived ROS production have been suggested to contribute to HFD-induced adipose tissue oxidative stress and insulin resistance in a mouse model of obesity. 13 In addition, an upregulation of NOX4 in the adipose tissue of obese Pima Indians compared with lean subjects was detected. 44 Our study confirmed upregulation of adipose tissue NOX4 expression upon HFD feeding (Supplementary Figure S5) . However, in view of the results of our current study NOX4 upregulation should be regarded as a defensive mechanism to limit adipose tissue expansion.
HFD-induced adipose tissue accumulation in NOX4-deficient mice was accompanied by exaggerated hepatosteatosis, one of the major obesity-related complications. Excessive liver triglyceride deposition was associated with a failure to upregulate the expression of CPT-1, the rate-limiting enzyme of liver mitochondrial FA oxidation. Decreased FA oxidation is an important factor in the development of liver steatosis. 45, 46 In the absence of appropriate CPT-1 activity, FA oxidation is incomplete, leading to the formation of ketone bodies. Indeed, NOX4-deficient mice presented higher ketone body levels after already 2 weeks of HFD regime. A sovereign role for NOX4-induced ROS production in liver lipid accumulation was also suggested by the compensatory downregulation of the triglyceride synthesis enzymes DGAT1 and DGAT2 observed in chow-diet fed NOX4-deficient mice that were undistinguishable from the levels detected in HFD-fed WT mice. NOX4 is a key mediator of TGF-b action in hepatocytes. 47 TGF-b production is elevated in steatotic livers triggering fibrosis through upregulation of a-SMA production by activated hepatic stellate cells. 36 In line with these data, NOX4-deficient mice failed to upregulate a-SMA expression in response to HFD feeding. In addition, expression of MMP-2 was elevated compared to HFD-fed WT mice, suggesting more intensive extracellular matrix breakdown and a defense against fibrotic tissue formation. These data are in agreement with studies demonstrating that diminished NOX4 function protects against the development of fibrosis in the lung. 15, 48 It is of importance that non-alcoholic fatty liver disease was suggested to be an independent risk factor for cardiovascular disease, though some controversial issues still remained unresolved. 49 --51 NOX4 has been demonstrated to have a decisive role in different cardiovascular pathologies. 52, 53 Thus, it is plausible to speculate that NOX4 might constitute a common factor between these two obesity-related pathologies, though complete exploration of this possible link will require further studies.
In a generalized way, our data demonstrated that the loss of NOX4 leads to latent molecular alterations in several organs, specifically in adipose tissue and liver. These changes do not manifest in an obvious phenotype if mice are kept in regular conditions but constitute a predisposition that can be brought into light by stress events for example, HFD feeding. Thus, mutations disabling NOX4 function could represent a state of imbalance in adipocyte redox homeostasis that would lead to a predisposition towards diet-induced obesity and insulin resistance. Along this line, upregulation of NOX4 expression in obese adipose tissue reported by others 13, 14 should be regarded as a counterregulatory mechanism to prevent adipose tissue hypertrophy and the onset of insulin resistance. Of potential significance is that in humans quantitative trait loci in the relation between obesity and diabetes was described in the chromosome region 11q14 --24, which also contains NOX4 (11q 14.2 --21). 54 An overview of the predisposing role of NOX4-deficiency in the development of HFD-induced obesity and insulin resistance is depicted in Figure 6 .
In summary, this study was aimed at examining the consequences of the loss of NOX4 function on the regulation of whole body metabolic and energy homeostasis. The results demonstrate that the lack of NOX4 function triggers a complex metabolic phenotype with adipose tissue hypertrophy and confers sensitivity towards HFD-induced obesity and insulin resistance. These data support recent observations that adequate ROS production is a vital component for the maintenance of whole body homeostasis Figure 6 . NOX4 deficiency predisposes towards HFD-induced obesity and insulin resistance. NOX4 deficiency results in increased adipocyte differentiation and hypertrophy, leading to WAT accumulation, hypoxia and inflammation in vivo. These alterations are latent but can be brought into light by nutritional challenge resulting in overt obesity, insulin resistance and hepatosteatosis.
and insulin sensitivity but also add a new dimension by defining NOX4 as a primary ROS source regulating adipose tissue function in this context.
